A phase 0/1 study of BDTX-1535 in recurrent glioblastoma (GBM) patients with EGFR alterations or fusions.

BDTX-1535 - Black Diamond Therap

https://virtual.oxfordabstracts.com/event/18018/submission/742

Nader Sanai; Yoshie Umemura; Vahuni Karapetyan; Tigran Margaryan; Dylan Huttenlocher; Jocelyn Harmon; Amy Hong; Wonsuk Yoo; An-Chi Tien; Artak Tovmasyan; Shwetal Mehta

Nov 7, 2024